Pan-Cancer Analysis of the Cuproptosis-Related Gene DLD

Background. Cancer affects millions of people each year and imposes a huge economic and social burden worldwide. Cuproptosis is a recently discovered novel mode of cell death. The exact function of the cuproptosis-related gene dihydrolipoamide dehydrogenase (DLD) and its role in pan-cancer is unknow...

Full description

Bibliographic Details
Main Authors: Jiahui Lin, Guowei Wang, Sha Cheng, Yanan Hu, Huan Li, Wanjiang Feng, Xiaoming Liu, Canxia Xu
Format: Article
Language:English
Published: Hindawi Limited 2023-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2023/5533444
_version_ 1797401062698647552
author Jiahui Lin
Guowei Wang
Sha Cheng
Yanan Hu
Huan Li
Wanjiang Feng
Xiaoming Liu
Canxia Xu
author_facet Jiahui Lin
Guowei Wang
Sha Cheng
Yanan Hu
Huan Li
Wanjiang Feng
Xiaoming Liu
Canxia Xu
author_sort Jiahui Lin
collection DOAJ
description Background. Cancer affects millions of people each year and imposes a huge economic and social burden worldwide. Cuproptosis is a recently discovered novel mode of cell death. The exact function of the cuproptosis-related gene dihydrolipoamide dehydrogenase (DLD) and its role in pan-cancer is unknown. Methods. Data were retrieved from the GTEx, TCGA, and multiple online websites. These data were used to assess the expression, prognosis, and diagnostic value of DLD in various tumors. The relationship of DLD with immune microenvironment immunomodulators, immune checkpoints, tumor mutational load (TMB), microsatellite instability (MSI), and oncology drug sensitivity was explored by correlation analysis. Results. The mRNA and protein expression of DLD differs in most cancers. Survival analysis showed that DLD was associated with prognosis with KIRC, KIRP, KICH, and UCS. DLD had a strong diagnostic value in KIRC, GBM, PAAD, and LGG (AUC > 0.9). DLD promoter methylation affects the aberrant expression of LIHC, LUSC, PAAD, READ, and THCA. DLD was negatively correlated with stromal score, immune score, and ESTIMATE score in UCEC, TGCT, LUSC, and SARC. In UCS, resting memory CD4 T cells and activated NK cells were significantly correlated with DLD expression. Significant correlations were also observed between DLD expression and immunomodulators, immune checkpoints, TMB, and MSI in various cancers. Importantly, we also identified a number of potential drugs that may target DLD. Conclusion. DLD expression is associated with a variety of tumor prognoses and plays an integral role in tumorigenesis, tumor metabolism, and immunity.
first_indexed 2024-03-09T02:03:30Z
format Article
id doaj.art-26b104b2352f435ea917f979aa265d15
institution Directory Open Access Journal
issn 1466-1861
language English
last_indexed 2024-03-09T02:03:30Z
publishDate 2023-01-01
publisher Hindawi Limited
record_format Article
series Mediators of Inflammation
spelling doaj.art-26b104b2352f435ea917f979aa265d152023-12-08T00:00:03ZengHindawi LimitedMediators of Inflammation1466-18612023-01-01202310.1155/2023/5533444Pan-Cancer Analysis of the Cuproptosis-Related Gene DLDJiahui Lin0Guowei Wang1Sha Cheng2Yanan Hu3Huan Li4Wanjiang Feng5Xiaoming Liu6Canxia Xu7Department of GastroenterologyCenter for Experimental MedicineDepartment of GastroenterologyCenter for Experimental MedicineDepartment of GastroenterologyCenter for Experimental MedicineDepartment of GastroenterologyDepartment of GastroenterologyBackground. Cancer affects millions of people each year and imposes a huge economic and social burden worldwide. Cuproptosis is a recently discovered novel mode of cell death. The exact function of the cuproptosis-related gene dihydrolipoamide dehydrogenase (DLD) and its role in pan-cancer is unknown. Methods. Data were retrieved from the GTEx, TCGA, and multiple online websites. These data were used to assess the expression, prognosis, and diagnostic value of DLD in various tumors. The relationship of DLD with immune microenvironment immunomodulators, immune checkpoints, tumor mutational load (TMB), microsatellite instability (MSI), and oncology drug sensitivity was explored by correlation analysis. Results. The mRNA and protein expression of DLD differs in most cancers. Survival analysis showed that DLD was associated with prognosis with KIRC, KIRP, KICH, and UCS. DLD had a strong diagnostic value in KIRC, GBM, PAAD, and LGG (AUC > 0.9). DLD promoter methylation affects the aberrant expression of LIHC, LUSC, PAAD, READ, and THCA. DLD was negatively correlated with stromal score, immune score, and ESTIMATE score in UCEC, TGCT, LUSC, and SARC. In UCS, resting memory CD4 T cells and activated NK cells were significantly correlated with DLD expression. Significant correlations were also observed between DLD expression and immunomodulators, immune checkpoints, TMB, and MSI in various cancers. Importantly, we also identified a number of potential drugs that may target DLD. Conclusion. DLD expression is associated with a variety of tumor prognoses and plays an integral role in tumorigenesis, tumor metabolism, and immunity.http://dx.doi.org/10.1155/2023/5533444
spellingShingle Jiahui Lin
Guowei Wang
Sha Cheng
Yanan Hu
Huan Li
Wanjiang Feng
Xiaoming Liu
Canxia Xu
Pan-Cancer Analysis of the Cuproptosis-Related Gene DLD
Mediators of Inflammation
title Pan-Cancer Analysis of the Cuproptosis-Related Gene DLD
title_full Pan-Cancer Analysis of the Cuproptosis-Related Gene DLD
title_fullStr Pan-Cancer Analysis of the Cuproptosis-Related Gene DLD
title_full_unstemmed Pan-Cancer Analysis of the Cuproptosis-Related Gene DLD
title_short Pan-Cancer Analysis of the Cuproptosis-Related Gene DLD
title_sort pan cancer analysis of the cuproptosis related gene dld
url http://dx.doi.org/10.1155/2023/5533444
work_keys_str_mv AT jiahuilin pancanceranalysisofthecuproptosisrelatedgenedld
AT guoweiwang pancanceranalysisofthecuproptosisrelatedgenedld
AT shacheng pancanceranalysisofthecuproptosisrelatedgenedld
AT yananhu pancanceranalysisofthecuproptosisrelatedgenedld
AT huanli pancanceranalysisofthecuproptosisrelatedgenedld
AT wanjiangfeng pancanceranalysisofthecuproptosisrelatedgenedld
AT xiaomingliu pancanceranalysisofthecuproptosisrelatedgenedld
AT canxiaxu pancanceranalysisofthecuproptosisrelatedgenedld